Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | $0.01 | $0.01 | $0.01 |
| Q2 2026 | 1 | $0.01 | $0.01 | $0.01 |
| Q3 2026 | 1 | $0.01 | $0.02 | $0.01 |
| Q4 2026 | 1 | $0.02 | $0.02 | $0.02 |
| Q1 2027 | 1 | $0.03 | $0.03 | $0.03 |
| Q2 2027 | 1 | $0.03 | $0.03 | $0.03 |
| Q3 2027 | 1 | $0.03 | $0.03 | $0.03 |
| Q4 2027 | 1 | $0.04 | $0.04 | $0.04 |
| Q1 2028 | 1 | $0.00 | $0.00 | $0.00 |
| Q2 2028 | 1 | $0.00 | $0.00 | $0.00 |
| Q3 2028 | 1 | $0.00 | $0.00 | $0.00 |
| Q4 2028 | 1 | $0.00 | $0.00 | $0.00 |
LifeStance Health Group Inc last posted its earnings results on Thursday, November 6th, 2025. The company reported $0.00277 earnings per share for the quarter, topping analysts' consensus estimates of $-0.01 by $0.01277. The company had revenue of 363.81 M for the quarter and had revenue of 1.25 B for the year. LifeStance Health Group Inc has generated $0 earnings per share over the last year ($-0.15 diluted earnings per share) and currently has a price-to-earnings ratio of -302.63. LifeStance Health Group Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2025 | Q3 2025 | -$0.01 | $0.00 | 0.01 | $356.87 M | $363.81 M |
| 08/07/2025 | Q2 2025 | -$0.03 | -$0.01 | 0.02 | $345.25 M | $345.31 M |
| 05/07/2025 | Q1 2025 | -$0.04 | $0.00 | 0.04 | N/A | $332.97 M |
| 02/27/2025 | Q4 2024 | -$0.04 | -$0.02 | 0.02 | N/A | $325.48 M |
| 11/07/2024 | Q3 2024 | -$0.07 | -$0.02 | 0.05 | $302.25 M | $312.72 M |
| 08/08/2024 | Q2 2024 | -$0.07 | -$0.06 | 0.01 | $305.85 M | $312.33 M |
| 05/09/2024 | Q1 2024 | -$0.09 | -$0.06 | 0.03 | N/A | $300.44 M |
| 02/28/2024 | Q4 2023 | -$0.09 | -$0.12 | -0.03 | N/A | $280.60 M |
| 11/08/2023 | Q3 2023 | -$0.07 | -$0.17 | -0.1 | N/A | $262.90 M |
| 08/09/2023 | Q2 2023 | -$0.09 | -$0.13 | -0.04 | N/A | $259.58 M |
| 05/10/2023 | Q1 2023 | -$0.11 | -$0.09 | 0.02 | N/A | $252.59 M |
| 03/09/2023 | Q4 2022 | N/A | -$0.12 | N/A | N/A | $229.36 M |
| 11/09/2022 | Q3 2022 | N/A | -$0.11 | N/A | N/A | $217.56 M |
| 08/10/2022 | Q2 2022 | N/A | -$0.19 | N/A | N/A | $209.53 M |
| 05/11/2022 | Q1 2022 | N/A | -$0.18 | N/A | N/A | $203.10 M |
| 03/17/2022 | Q4 2021 | N/A | -$0.33 | N/A | N/A | $190.00 M |
| 11/10/2021 | Q3 2021 | N/A | -$0.35 | N/A | N/A | $173.84 M |
| 08/11/2021 | Q2 2021 | N/A | -$0.22 | N/A | N/A | $160.55 M |
| 03/31/2021 | Q1 2021 | N/A | -$0.02 | N/A | N/A | $143.13 M |
| 12/31/2020 | Q4 2020 | N/A | -$0.02 | N/A | N/A | $118.12 M |
In the previous quarter, LifeStance Health Group Inc (:LFST) reported $0.00277 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.01 by $0.01277.
The conference call for LifeStance Health Group Inc's latest earnings report can be listened to online.
The conference call transcript for LifeStance Health Group Inc's latest earnings report can be read online.
LifeStance Health Group Inc (:LFST) has a recorded annual revenue of $1.25 B.
LifeStance Health Group Inc (:LFST) has a recorded net income of $-57,443,000.LifeStance Health Group Inc has generated $-0.15 earnings per share over the last four quarters.
LifeStance Health Group Inc (:LFST) has a price-to-earnings ratio of -302.63 and price/earnings-to-growth ratio is -6.92.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED